71 results
PRE 14A
AXLA
Axcella Health Inc.
7 Aug 23
Preliminary proxy
4:15pm
conduct and ethics for any officer or director, we will disclose the nature of such amendment or waiver on our website or in a current report on Form
8-K
EX-10.1
bi68biyktcwuz
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
424B5
puypohtqqp1a2mevoa
13 Oct 22
Prospectus supplement for primary offering
7:55am
D
g67l3
23 Sep 22
$12M in debt / options, sold $6M, 2 investors
4:32pm
8-K
EX-10.1
fcspkxfdislog57sjdly
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
mmh 6fi6o84nko2i
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am
424B5
pu45p8
16 Mar 22
Prospectus supplement for primary offering
8:00am
8-K
EX-10.1
e71g8laarw8m0ku0epg
7 Sep 21
Entry into a Material Definitive Agreement
4:16pm